Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
rel-trans-N1,N1-Diethyl-1,4-cyclohexanediamine can be synthesized from trans-N-Boc-1,4-cyclohexanediamine (B646235), a compound used in the preparation of orally bioavailable and selective V1A receptor antagonist.